Novartis (India)

Recent papers from Novartis (India)

1. Ianalumab for the Treatment of Patients with Sjögren’s DiseaseNew England Journal of Medicine · 2026
2. Global burden of dengue on healthcare systems: a meta-analysis of healthcare resource utilisationEClinicalMedicine · 2026
3. Sample size variation in single-time post-dose assessment vs multi-time post-dose assessmentF1000Research · 2026
4. LC–HRMS/MS Characterization of Hydrolytic and Photolytic Degradation Pathways of Ripretinib Following Forced Stress StudiesRapid Communications in Mass Spectrometry · 2026
5. IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas modelProceedings of the National Academy of Sciences · 2026
6. Elevated lipoprotein(a) is associated with increased risk for MACE in patients with premature and recurrent atherosclerotic cardiovascular disease: a large real-world cohort studyBMC Cardiovascular Disorders · 2026
7. Clinical efficacy and safety of asciminib in chronic myeloid leukemia-chronic phase (CML-CP) in real-world settings: a systematic literature reviewBMC Cancer · 2026
8. Understanding barriers to effective malaria diagnosis and treatment: A mixed-methods study in Uganda, Nigeria, and Ivory CoastPLOS Global Public Health · 2026
9. Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studiesThe Lancet Respiratory Medicine · 2026
10. Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALLJournal of Clinical Oncology · 2026
11. Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)]EClinicalMedicine · 2026
12. Chronic Spontaneous Urticaria (CSU) in Chinese Patients: Real-World Evidence of Disease Control and Treatment Patterns from the Urticaria Voices StudyDermatology and Therapy · 2026
13. Publisher Correction: Randomized-controlled trial of sacubitril/valsartan and amlodipine combination in Japanese uncontrolled hypertensive patients (J-SAMIT)Hypertension Research · 2026
14. Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemiaHaematologica · 2026
15. Exploring the Ethnobotanical, Nutritional, and Medicinal Potential of Ensete ventricosum (Welw.) Cheesman: A Mini ReviewCurrent Traditional Medicine · 2026
16. Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS studyJournal of Neurology · 2026
17. Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON studyThe Journal of Headache and Pain · 2026
18. Interactions and Conformational Plasticity of Human Uncoupling Protein 1 in Response to Small-Molecule Analogues: Insights from Molecular Dynamics SimulationsACS Omega · 2026
19. Secukinumab for Giant Cell ArteritisNEJM Evidence · 2026
20. Phase 3 Trial of Secukinumab in Polymyalgia RheumaticaNew England Journal of Medicine · 2026